Pfizer

Pfizer Inc (NYSE:PFE) has experienced a daily gain of 3.37% and a 3-month loss of -7.09%. Despite these fluctuations, its Earnings Per Share (EPS) (EPS) remains...

Text size The pharmaceutical companies set to dominate the multi-billion dollar market for new obesity medicines could have a serious challenger from the small...

(Bloomberg) -- Structure Therapeutics Inc. jumped to a record high Friday after new data on its oral weight-loss drug fueled expectations that the San Francisco...

Undoubtedly, Pfizer PFE, Moderna MRNA, and AstraZeneca AZN were heroes in the stock market and in a literal sense to society with the prompt emergence of their...

The updated vaccine (XBB.1.5 variant-adapted monovalent COVID-19 vaccine) is now authorized in Canada for individuals 6 months of age and older The updated vac...

In the ever-evolving world of the stock market, uncovering potential gold mines is paramount for smart investing. One promising area to consider is undervalued...

Fior Markets has presented updated research on Global Antifungal Drugs Market 2023 to 2032 that would come in handy to understand the competitors in the market....

Pharma companies across the globe, including Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA), are harnessing the potential of mRNA which is creating plent...

Pfizer, Inc. PFE shares are trading lower Wednesday. The stock hit a new 52-week low and has fallen more than 24% over the last year. What To Know: Pfizer fac...

Ginkgo Bioworks Holdings Inc DNA shares are trading higher Wednesday after the company announced a collaboration with Pfizer Inc PFE focused on the discovery of...